Galderma Shares Rise on Strong 2026 Sales Guidance

Shares of the Switzerland skincare firm GALDERMA GROUP AG rose on Thursday after the company reported strong annual results and issued a positive outlook for 2026. The firm recorded full-year net sales of $5.21 billion, representing a 17.7% increase. This growth was largely propelled by the Therapeutic Dermatology division, which expanded by more than 50% following the introduction of Nemluvio, a treatment for chronic conditions like atopic dermatitis and prurigo nodularis.